However, it has been demonstrated that EMT contributes to evasion of immune surveillance in breast cancer [60] and that PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200 [61]. Here, CD274 is linked to breast cancer.